MOS Stock Cash Flow Statements

The Mosaic Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

The Mosaic Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-05-31	2013-02-28	2012-11-30	2012-08-31	2012-05-31	2012-02-29	2011-11-30	2011-08-31	2011-02-28	2010-11-30	2010-08-31	2010-02-28	2009-11-30	2009-08-31	2009-02-28	2008-11-30	2008-08-31	2008-02-29	2007-11-30	2007-08-31	2007-02-28	2006-11-30	2006-08-31	2005-08-31	2005-02-28

cash flows from operating activities:
net earnings including noncontrolling interests	419,700,000	250,000,000	165,700,000	130,700,000	-150,900,000	56,500,000	368,000,000	3,100,000	379,100,000	459,000,000	528,500,000	856,200,000	1,043,800,000	1,185,700,000	376,500,000	438,800,000	158,200,000	828,300,000	-4,600,000	45,900,000	-204,000,000	-950,400,000	-40,000,000	-230,300,000	129,900,000	112,000,000	249,700,000	68,100,000	40,100,000	-429,800,000	229,600,000	97,100,000	-1,100,000	14,600,000	40,700,000	-11,000,000	256,900,000	155,500,000	160,700,000	391,000,000	294,600,000	361,600,000	202,900,000	248,200,000	217,700,000	125,800,000	485,400,000	345,400,000	630,300,000	430,700,000		271,900,000	625,600,000	526,400,000
adjustments to reconcile net earnings including noncontrolling interests to net cash from operating activities:
depreciation, depletion and amortization	261,700,000	243,000,000	282,100,000	237,900,000	264,400,000	241,100,000	257,700,000	238,700,000	244,200,000	220,000,000	233,000,000	229,200,000	245,000,000	226,700,000	186,100,000	203,500,000	209,100,000	208,500,000	205,900,000	215,400,000	217,800,000	233,100,000	210,800,000	220,700,000	218,100,000	235,100,000	214,500,000	216,800,000	217,500,000	172,000,000	168,800,000	165,900,000	158,800,000	165,500,000	172,700,000	189,300,000	183,700,000	185,000,000	180,900,000	191,100,000	182,800,000	192,700,000	189,500,000	194,400,000	174,300,000	166,100,000	167,800,000	152,200,000	147,400,000	137,400,000	139,700,000	127,900,000	120,200,000	120,300,000	114,100,000	105,700,000	104,700,000	101,600,000	138,900,000	92,100,000	90,400,000	89,400,000	87,700,000							74,300,000	72,400,000
deferred and other income taxes	35,600,000	-11,000,000	-179,100,000	-3,600,000	115,100,000	-75,300,000	-228,700,000	-36,200,000	4,900,000	-1,200,000	11,600,000	35,500,000	167,100,000	130,200,000	109,000,000	75,900,000	-37,000,000	-533,400,000	-26,800,000	-16,500,000	-107,300,000	-258,400,000	26,700,000	-34,900,000	5,300,000	-89,500,000	83,300,000	-32,400,000	-63,200,000	558,500,000	19,900,000	-25,100,000	59,100,000	-54,700,000	-58,100,000	-16,400,000	-53,400,000
equity in net (earnings) of nonconsolidated companies, net of dividends	-600,000	-400,000	-6,500,000	-4,500,000	-22,200,000	-22,500,000	3,300,000	-15,900,000	-12,900,000	-6,300,000
accretion expense for asset retirement obligations	32,600,000	32,200,000	30,300,000	26,800,000	26,900,000	27,200,000	26,100,000	24,000,000	23,200,000	22,800,000	22,400,000	19,600,000	20,000,000	19,600,000	17,700,000	18,000,000	17,100,000	17,300,000	16,700,000	16,700,000	17,300,000	18,100,000	15,600,000	13,400,000	15,300,000	10,800,000	12,700,000	12,400,000	12,100,000	6,100,000	6,500,000	6,600,000	6,500,000	10,400,000	10,200,000	10,400,000	9,400,000	8,700,000	8,200,000	7,700,000	7,800,000	12,300,000	8,600,000	10,700,000	10,500,000	9,900,000	7,300,000	9,600,000	8,300,000	8,100,000	11,200,000	7,100,000	7,000,000	7,100,000	9,700,000	7,200,000	7,100,000	8,200,000	7,100,000	7,900,000	12,500,000	5,700,000	8,800,000							13,400,000
share-based compensation expense	8,400,000	9,300,000	5,100,000	5,500,000	11,900,000	9,300,000	6,000,000	6,000,000	8,600,000	12,400,000	5,900,000	6,500,000	-900,000	16,400,000	5,100,000	4,300,000	14,900,000	12,600,000	7,100,000	8,200,000	-10,100,000	2,900,000	2,900,000	6,800,000	15,300,000	1,800,000	3,000,000	7,000,000	15,700,000	3,500,000	3,600,000	5,000,000	15,900,000	4,000,000	4,200,000	5,400,000	16,900,000	5,400,000	2,000,000	29,300,000	4,600,000	5,100,000	5,700,000	8,600,000	34,900,000	14,100,000	2,700,000	2,900,000	4,800,000	17,800,000	3,300,000	3,100,000	3,200,000	13,800,000
unrealized (gain) loss on equity securities	-216,300,000	116,600,000
unrealized (gain) loss on derivatives	-54,600,000	-57,700,000											32,400,000	-98,800,000																		-5,000,000	1,800,000		9,800,000	-37,100,000	-54,200,000		12,700,000	-31,500,000	45,400,000			-37,500,000	7,900,000													-19,900,000					117,200,000
foreign currency adjustments	-192,000,000	-159,000,000	345,200,000	-232,000,000	254,600,000	94,900,000	-57,800,000	118,100,000	-103,000,000	-51,300,000	-26,800,000	35,200,000	242,600,000	-318,900,000	97,300,000	-150,900,000	34,500,000	-131,800,000	-61,400,000
amortization of debt financing fees
other	68,300,000	11,400,000	-3,600,000	7,600,000	48,100,000	19,700,000	-44,500,000	30,800,000	24,700,000	26,500,000	-30,700,000	19,800,000	38,100,000	11,800,000	9,100,000	-17,900,000	800,000	-19,500,000	-9,600,000	-700,000	10,700,000	1,900,000	-6,000,000	-4,400,000	5,600,000	-2,900,000	14,200,000	-1,300,000	8,300,000	2,500,000	0	-3,700,000	9,000,000	17,400,000	-5,400,000	-400,000	6,600,000	26,800,000	5,300,000	11,200,000	4,100,000	4,500,000	-2,500,000	4,900,000	4,000,000	-3,100,000	-8,100,000	11,100,000	-4,700,000	14,100,000	600,000	9,700,000	-1,400,000	-500,000	15,300,000	-2,400,000	1,700,000	700,000	2,500,000	-700,000	7,700,000	5,600,000	-1,000,000	5,700,000	100,000	800,000	700,000	-200,000	100,000	-1,700,000
changes in assets and liabilities:
receivables	-45,000,000	59,600,000	-136,200,000	273,600,000	-109,000,000	30,800,000	193,700,000	-203,700,000	225,600,000	310,700,000	213,900,000	292,200,000	-808,300,000	87,000,000	-175,300,000	-44,900,000	-1,500,000	-91,300,000	-105,100,000	28,000,000	14,800,000	1,400,000	-134,700,000	108,900,000	59,000,000	37,500,000	-163,800,000	69,700,000	62,500,000	-84,400,000	-58,200,000	5,700,000	45,700,000	-118,600,000	-134,900,000	239,900,000	17,100,000	-1,600,000	-104,400,000	37,300,000	8,000,000	-162,500,000	6,100,000	14,800,000	-84,900,000	131,700,000	-155,200,000	-77,700,000	-75,300,000	11,500,000	-120,900,000	253,200,000	-144,400,000	130,600,000	-137,600,000	-87,600,000	41,300,000	-32,300,000	-96,500,000	111,500,000	269,400,000	577,600,000	-521,000,000							-16,400,000	-17,200,000
inventories	-215,700,000	-162,400,000	241,700,000	-347,500,000	-54,900,000	-114,900,000	-46,200,000	636,600,000	229,800,000	241,200,000	292,900,000	-224,100,000	-536,800,000	-281,600,000	-172,700,000	-221,300,000	-180,700,000	-1,000,000	263,000,000	-46,200,000	-24,400,000	227,200,000	314,500,000	-109,100,000	-304,500,000	-299,300,000	171,500,000	-222,000,000	-147,600,000	98,900,000	51,100,000	-172,400,000	-133,300,000	104,500,000	195,100,000	-70,900,000	34,300,000	-10,900,000	-73,400,000	-77,900,000	108,500,000	-168,000,000	74,500,000	-8,900,000	-27,300,000	-2,500,000	19,200,000	-62,200,000	-26,100,000	-246,400,000	72,700,000	-123,400,000	193,000,000	-135,800,000	-314,900,000	227,700,000	-42,300,000	15,300,000	77,800,000	78,900,000	176,200,000	-1,900,000	-590,200,000							-21,400,000	-116,700,000
other current and noncurrent assets	-31,200,000	55,100,000		-117,500,000	-117,200,000	55,000,000		-71,500,000	-81,500,000	-194,300,000		28,400,000	-139,000,000	-88,100,000	-33,200,000	-67,100,000	14,000,000		-14,700,000	162,900,000	-107,900,000		3,500,000	-700,000	-66,000,000		-25,000,000	86,600,000	-137,500,000		28,600,000	-3,600,000	-67,700,000		23,000,000	39,300,000	-22,000,000		-82,400,000	-114,600,000	-36,500,000		50,300,000	15,000,000	151,400,000	-167,800,000		106,100,000	-85,400,000	72,800,000		-191,300,000	-101,100,000	1,500,000	-37,900,000	15,500,000	61,900,000				-19,100,000
accounts payable and accrued liabilities	450,600,000	-331,900,000	-161,400,000	219,300,000	516,200,000	-477,700,000	-128,600,000	-194,800,000	109,900,000	-841,600,000	-324,400,000	-528,700,000	1,369,800,000	-296,900,000	-54,200,000	659,400,000	64,600,000	-77,100,000	19,400,000	58,300,000	332,700,000	-184,700,000	91,500,000	154,500,000	-186,700,000	-124,500,000	-50,600,000	592,000,000	-74,900,000	-27,300,000	-257,600,000	180,600,000	38,600,000	-81,200,000	-173,800,000	148,800,000	-137,700,000
other noncurrent liabilities	64,900,000	-11,900,000	-13,600,000	155,300,000	35,300,000	43,300,000	22,300,000	28,800,000	60,500,000	-3,300,000	11,800,000	103,600,000	-56,100,000	-59,400,000	31,800,000	-13,400,000	20,600,000	-2,800,000	53,100,000	61,000,000	-21,600,000	9,500,000	-1,900,000	-6,000,000	-22,300,000	-1,400,000	18,400,000	15,900,000	8,200,000	10,200,000	3,900,000	-7,400,000	12,700,000	25,100,000	1,000,000	19,100,000	700,000	12,100,000	-14,300,000	21,700,000	-17,700,000	-121,800,000	-17,100,000	60,900,000	-29,900,000	-83,200,000	-1,900,000	-37,700,000	-123,200,000	2,000,000	63,100,000	74,300,000	-55,900,000	-15,500,000	-6,700,000	-47,800,000	300,000	-32,700,000	11,100,000	9,600,000	-87,200,000	23,100,000	-80,400,000
net cash from operating activities	609,500,000	42,900,000	219,300,000	312,900,000	847,000,000	-80,000,000	538,100,000	647,400,000	1,072,700,000	149,000,000	955,700,000	888,800,000	1,585,100,000	506,200,000	422,700,000	1,015,100,000	318,800,000	238,400,000	340,600,000	813,700,000	189,900,000	277,600,000	486,000,000	507,300,000	-175,500,000	150,000,000	523,800,000	807,000,000	-71,000,000	411,200,000	135,500,000	242,800,000	146,000,000	321,200,000	95,800,000	583,200,000	265,900,000	286,900,000	282,100,000	583,100,000	655,500,000	381,800,000	488,600,000	796,300,000	627,000,000	-45,000,000	854,700,000	371,100,000	322,400,000	339,300,000	1,229,300,000	404,500,000	517,700,000	554,300,000	365,900,000	531,700,000	556,200,000	476,700,000	174,800,000	172,400,000	-11,200,000	386,500,000	561,500,000	528,000,000	542,500,000	438,400,000	147,500,000	142,200,000	150,600,000	81,200,000	-83,600,000
cash flows from investing activities:
capital expenditures	-304,600,000	-340,800,000	-294,100,000	-240,800,000	-333,900,000	-383,000,000	-358,900,000	-411,700,000	-310,300,000	-321,500,000	-340,500,000	-353,700,000	-262,600,000	-290,500,000	-340,000,000	-297,200,000	-288,600,000	-384,800,000	-265,100,000	-257,200,000	-263,500,000	-341,100,000	-322,300,000	-294,900,000	-313,900,000	-289,100,000	-241,000,000	-201,100,000	-223,300,000	-230,200,000	-197,600,000	-168,500,000	-223,800,000	-209,400,000	-196,400,000	-201,700,000	-235,600,000	-298,100,000	-245,300,000	-227,400,000	-229,500,000	-251,800,000	-188,400,000	-214,000,000	-274,900,000	-332,500,000	-347,900,000	-397,800,000	-393,500,000	-449,100,000	-449,000,000	-411,800,000	-387,100,000	-391,400,000	-311,600,000	-291,000,000	-294,700,000	-208,800,000	-190,600,000	-236,200,000	-196,700,000	-223,200,000	-186,900,000	-86,600,000	-79,100,000	-82,100,000	-61,900,000	-29,400,000	-85,200,000	-90,700,000	-65,700,000
free cash flows	304,900,000	-297,900,000	-74,800,000	72,100,000	513,100,000	-463,000,000	179,200,000	235,700,000	762,400,000	-172,500,000	615,200,000	535,100,000	1,322,500,000	215,700,000	82,700,000	717,900,000	30,200,000	-146,400,000	75,500,000	556,500,000	-73,600,000	-63,500,000	163,700,000	212,400,000	-489,400,000	-139,100,000	282,800,000	605,900,000	-294,300,000	181,000,000	-62,100,000	74,300,000	-77,800,000	111,800,000	-100,600,000	381,500,000	30,300,000	-11,200,000	36,800,000	355,700,000	426,000,000	130,000,000	300,200,000	582,300,000	352,100,000	-377,500,000	506,800,000	-26,700,000	-71,100,000	-109,800,000	780,300,000	-7,300,000	130,600,000	162,900,000	54,300,000	240,700,000	261,500,000	267,900,000	-15,800,000	-63,800,000	-207,900,000	163,300,000	374,600,000	441,400,000	463,400,000	356,300,000	85,600,000	112,800,000	65,400,000	-9,500,000	-149,300,000
purchases of available-for-sale securities - restricted	-395,100,000	-102,500,000	-367,700,000	-430,900,000	-106,400,000	-624,700,000	-201,100,000	-227,900,000	-207,200,000	-604,600,000	-302,900,000	-33,700,000	-368,100,000	-57,800,000	-122,800,000	-76,800,000	-123,700,000	-119,500,000	-150,700,000	-138,500,000	-210,000,000	-73,300,000	-250,100,000	-47,300,000	-186,900,000	-48,400,000	-228,500,000	-71,900,000	-185,700,000	-130,000,000	-280,000,000	-530,200,000	-736,100,000	-925,000,000
proceeds from sale of available-for-sale securities - restricted	380,300,000	97,100,000	382,000,000	421,100,000	78,200,000	619,800,000	197,400,000	214,900,000	205,600,000	591,200,000	298,400,000	29,400,000	363,300,000	51,900,000	117,100,000	75,300,000	110,800,000	117,700,000	148,500,000	137,200,000	203,800,000	65,000,000	246,400,000	39,500,000	182,300,000	48,300,000	221,100,000	65,400,000	184,000,000	124,400,000	277,600,000	521,800,000	734,300,000	890,400,000
net cash from investing activities	-318,500,000	-340,800,000	-276,500,000	-247,700,000	-349,000,000	-387,800,000	-362,200,000	-422,100,000	-311,500,000	-221,400,000	-343,100,000	-354,600,000	-264,700,000	-297,200,000	-351,000,000	-271,100,000	-308,500,000	-394,800,000	-267,100,000	-257,900,000	-269,700,000	-346,800,000	-326,500,000	-358,700,000	-328,900,000	-283,800,000	-243,800,000	-196,700,000	-1,220,400,000		-220,700,000	-177,000,000	-245,600,000		-382,000,000	-356,500,000	-273,900,000		-822,600,000	-343,400,000	-182,900,000		-158,100,000	-360,300,000	-1,634,300,000	-465,700,000		-390,100,000	-396,100,000	-443,800,000		-404,700,000	-384,600,000	-392,500,000	-271,600,000	740,000,000	-681,600,000	-204,700,000	-154,600,000	-236,100,000	-192,900,000	491,400,000	-187,800,000	-56,900,000	-79,100,000	-73,700,000	-74,200,000	-29,600,000	-85,100,000	-80,100,000	-66,200,000
cash flows from financing activities:
payments of short-term debt	-3,431,300,000	-3,618,700,000	-4,358,300,000	-4,253,100,000	-3,572,000,000	-4,596,200,000	-3,070,100,000	-1,466,300,000	-2,167,700,000	-3,127,900,000	-1,602,600,000	-39,300,000	524,000,000	-643,300,000	0			-209,800,000	-511,200,000	-688,900,000	-132,600,000	-112,500,000	-119,000,000	-269,000,000	-53,700,000	-24,300,000	-31,200,000			-78,200,000	-258,000,000	-250,700,000	-14,500,000	-87,600,000	-160,000,000	-99,600,000	-74,100,000	-70,200,000	-152,200,000	-112,100,000	-32,700,000	-1,000,000	-95,500,000	-65,500,000	-58,400,000	-42,900,000	-132,400,000	-60,800,000	-36,400,000	-33,500,000	-59,100,000	-17,500,000	-46,900,000	-25,300,000	-68,600,000	-134,000,000	-90,900,000	-134,000,000	-57,900,000	-63,200,000	-116,700,000	-51,800,000	-141,500,000	-134,200,000	-185,400,000	-91,600,000	-100,500,000	-181,000,000	-256,100,000
proceeds from issuance of short-term debt	3,237,000,000	3,804,500,000	4,460,000,000	4,423,400,000	3,249,000,000	4,900,400,000	3,170,000,000	1,537,600,000	1,943,000,000	3,356,500,000	1,827,700,000	22,500,000	-684,100,000	814,400,000	0	10,000,000	15,000,000	3,800,000	122,300,000	289,600,000	1,105,400,000	69,700,000	116,800,000	198,500,000	206,000,000	9,900,000	38,000,000	41,900,000	65,300,000	23,300,000	264,700,000	200,400,000	143,000,000	35,100,000	159,200,000	112,500,000	90,200,000	77,200,000	144,000,000	129,100,000	29,400,000	14,200,000	83,200,000	36,900,000	65,900,000	57,200,000	139,900,000	100,800,000	39,900,000	8,500,000	20,200,000	70,800,000	61,600,000	15,300,000	88,300,000	112,600,000	83,700,000	90,700,000	90,800,000	77,700,000	95,100,000	53,400,000	118,600,000	258,100,000	136,800,000	106,100,000	84,800,000	129,000,000	231,600,000
payments of inventory financing arrangement	-602,200,000	-199,500,000		-703,900,000	-500,900,000	-200,300,000		0				-200,600,000
proceeds from inventory financing arrangement	603,000,000	401,600,000	399,400,000	401,800,000	502,100,000	701,200,000	0	0	200,600,000	400,800,000	0	401,100,000
payments of structured accounts payable arrangements	-263,700,000	-204,900,000	-232,700,000	-104,800,000	-191,400,000	-226,100,000	-422,300,000	-238,700,000	-390,700,000	-381,200,000	-332,500,000	-373,400,000	-308,200,000	-462,500,000	-333,000,000	-181,700,000	-161,000,000	-308,200,000	-146,400,000	-288,700,000	-412,900,000	-214,600,000	-164,400,000	-278,400,000	-319,700,000	-179,700,000	-144,200,000	-202,500,000	-235,700,000	-179,700,000	-83,000,000	-120,500,000	-35,300,000	-188,500,000	-109,100,000	-270,300,000	-224,300,000	-84,300,000
proceeds from structured accounts payable arrangements	275,800,000	182,100,000	227,100,000	234,400,000	184,900,000	90,900,000	214,200,000	238,600,000	425,600,000	169,800,000	439,900,000	224,200,000	232,800,000	563,600,000	235,200,000	212,800,000	314,700,000	316,400,000	355,700,000	193,700,000	171,600,000	259,000,000	419,800,000	235,900,000	209,500,000	243,900,000	259,200,000	157,200,000	173,800,000	193,000,000	226,400,000	140,100,000	107,300,000	92,300,000	135,300,000	110,200,000	95,800,000	305,400,000
proceeds from issuance of long-term debt																										0	100,000			1,249,900,000	0	200,000	1,300,000					-1,200,000	2,100,000			4,800,000	803,100,000	3,900,000	200,000	2,700,000	100,000	600,000	100,000	1,100,000	-200,000	1,500,000	741,400,000	5,300,000	16,900,000			0	0	600,000	0	0	100,000				1,997,700,000	100,000	200,000		399,100,000
collections of transferred receivables	-1,800,000	105,800,000	95,400,000	103,500,000	125,000,000	101,600,000	0	290,900,000	569,500,000	608,200,000	1,068,500,000	600,100,000	236,600,000	446,900,000	121,600,000
payments of transferred receivables	5,000,000	-105,800,000	-96,900,000	-102,100,000	-125,900,000	-100,600,000	0	-381,100,000	-480,500,000	-607,000,000	-1,069,700,000	-598,900,000	-389,000,000	-375,600,000	-102,200,000
payments of long-term debt	-27,900,000	-11,700,000	-12,000,000	-12,700,000	-27,100,000	-15,400,000	-950,500,000	-15,700,000	-14,100,000	-15,000,000	-565,800,000	-15,900,000	-14,500,000	-14,100,000	-466,000,000	-14,200,000	-114,500,000	-16,000,000	-19,500,000	-17,200,000	-14,200,000	-15,400,000	-11,500,000	-11,300,000	-10,100,000	-80,500,000	-408,500,000	-107,000,000	-206,900,000	-96,000,000	-2,800,000	-1,800,000	-1,600,000	-726,100,000	-41,200,000	-600,000	-1,200,000	-1,200,000	-56,000,000	-1,800,000	-600,000	-600,000	-500,000	-700,000	-300,000	-700,000	-600,000	-500,000	-200,000	-200,000	-100,000	-512,500,000	-28,400,000	-1,800,000	-459,600,000	-3,800,000	-3,700,000	-3,500,000	-17,700,000	-17,400,000	-3,800,000	-67,300,000	-33,800,000	-158,800,000	-454,400,000	-183,100,000	-1,760,700,000	-5,400,000	-6,100,000		-267,200,000
repurchases of stock			-25,000,000	-50,000,000	-52,000,000	-108,400,000	-150,000,000	-150,000,000	0	-456,000,000	-64,000,000	-601,800,000	-577,300,000	-422,100,000								-32,800,000												0	0	0	-75,000,000		-74,900,000	-500,100,000	-134,400,000		-375,000,000	-454,800,000	-1,677,900,000
cash dividends paid	-70,100,000	-70,900,000	-66,500,000	-66,800,000	-67,700,000	-69,700,000	-65,100,000	-66,400,000	-67,700,000	-152,400,000	-34,400,000	-68,800,000	-53,900,000	-40,600,000	-28,400,000	-28,600,000	-18,900,000	-19,000,000	-18,900,000	-19,000,000	-18,900,000	-19,000,000	-19,300,000	-19,300,000	-9,600,000	-9,600,000	-9,700,000	-9,600,000	-9,600,000	-8,800,000	-52,700,000	-52,700,000	-96,400,000	-96,300,000	-96,400,000	-96,200,000	-96,200,000	-96,900,000	-98,300,000	-98,100,000	-91,400,000	-93,900,000	-93,800,000	-95,100,000	-99,700,000						-53,400,000	-21,400,000	-22,300,000	-22,400,000	-22,400,000	-22,300,000	-22,300,000	-600,900,000	-22,600,000	-22,200,000	-22,200,000	-22,200,000	-22,200,000							-2,600,000
dividends paid to non-controlling interest			-14,300,000	-5,800,000	-3,600,000	-8,200,000
net cash from financing activities	-285,200,000	272,000,000	36,700,000	-137,900,000	-488,600,000	457,900,000	-410,700,000	-254,200,000	-606,600,000	-209,000,000	-573,000,000	-649,500,000	-1,331,200,000	-125,000,000	-618,300,000	-82,100,000	121,700,000	-232,900,000	-218,500,000	-530,700,000	698,300,000	-65,900,000	105,200,000	-143,800,000	22,300,000	-45,200,000	-296,400,000	-169,900,000	-213,300,000	1,089,600,000	94,300,000	-85,300,000	102,200,000		-111,600,000	-242,500,000	-280,000,000	135,400,000	-224,600,000	-577,200,000	-227,000,000	-318,500,000	323,300,000	-574,500,000	-1,770,300,000	-89,500,000		-65,600,000	-103,600,000	-131,800,000		-479,900,000	-460,400,000	-28,800,000	-452,400,000	-30,200,000	-33,000,000	-639,000,000	-5,700,000	-27,500,000	-47,700,000	-83,100,000	-76,500,000	17,100,000	-485,700,000	-150,300,000	103,600,000	-36,900,000	-28,900,000	-37,300,000	138,400,000
effect of exchange rate changes on cash	17,900,000	-400,000	-6,600,000	54,500,000	-6,200,000	-3,800,000	-6,200,000	-10,100,000	9,200,000	4,300,000	-8,000,000	-19,600,000	-33,200,000	31,100,000	-32,100,000	69,200,000	-20,100,000	38,600,000	-1,500,000	-15,400,000	-68,900,000	8,900,000	-24,200,000	10,800,000	13,500,000	-900,000	-11,200,000	-65,000,000	13,400,000	-8,300,000	18,300,000	1,500,000	3,000,000	-10,000,000	-8,000,000	17,400,000	69,400,000	-31,400,000	-159,900,000	30,000,000	-102,800,000	-72,900,000	-50,200,000	14,800,000	-24,800,000	23,300,000	-23,700,000	-13,400,000	3,200,000	20,100,000	-82,600,000	54,400,000	-83,100,000	-1,400,000	50,800,000	55,200,000	-1,900,000	10,700,000	34,900,000	-13,300,000	-30,800,000	-172,900,000	-68,200,000	3,800,000	25,300,000	4,200,000			4,900,000	-7,500,000
net change in cash, cash equivalents and restricted cash	23,700,000	-26,300,000	-27,100,000	-18,200,000	3,200,000	-13,700,000	-241,000,000	-39,000,000	163,800,000	-277,100,000	31,600,000	-134,900,000	-44,000,000	115,100,000	-578,700,000	731,100,000	111,900,000	-350,700,000	-146,500,000	9,700,000	549,600,000	-126,200,000	240,500,000	15,600,000	-468,600,000	-179,900,000	-27,600,000	375,400,000	-1,491,300,000		27,400,000	-18,000,000	5,600,000
cash, cash equivalents and restricted cash - december 31	0	305,000,000		0	0	360,800,000		0	0	754,100,000		0	0	786,300,000	0	0	594,400,000		0
cash, cash equivalents and restricted cash - june 30
cash, cash equivalents and restricted cash - march 31		278,700,000				347,100,000				477,000,000				901,400,000			706,300,000
cash flows from operating activities
(gain) loss on sale of securities
pension settlement loss							0
gain on sale of business							0	0	0	-56,500,000
gain on sale of equity investment																																																							0
other current assets and noncurrent assets
cash flows from investing activities
proceeds from sale of business							0	0	0	158,400,000																																																0
acquisition of business							0	0	0	-41,000,000																																	-22,200,000	0	-1,353,600,000
cash flows from financing activities
payments from inventory financing arrangement
cash, cash equivalents and restricted cash—beginning of year
cash, cash equivalents and restricted cash—end of year
unrealized gain on derivatives				-38,700,000					-46,100,000	5,900,000						-38,400,000	-7,100,000		-40,200,000	-4,700,000	51,900,000		-10,600,000	1,600,000	-46,900,000	44,600,000	-12,000,000	12,100,000	14,200,000	14,000,000																				-41,300,000	13,200,000	-8,700,000			-17,000,000	-22,300,000	15,700,000			-38,400,000
cash, cash equivalents and restricted cash - september 30
unrealized loss on derivatives						32,600,000																																																17,300,000							19,000,000
accretion expense for leases									5,700,000	5,000,000	4,800,000	4,600,000	3,300,000	3,200,000	3,100,000	3,400,000	3,800,000	5,200,000	5,400,000
mine closure costs															0
loss on sale of securities
write down of inventory to net realizable value
equity in net (earnings) loss of nonconsolidated companies, net of dividends											-52,800,000	-72,100,000	-35,900,000	-30,700,000
purchases of held-to-maturity securities															-2,400,000	0	-800,000	-5,400,000	0	0	-700,000	-900,000	-1,500,000	0	-13,000,000
proceeds from sale of held-to-maturity securities														1,700,000	0	0	800,000	0	900,000	0	800,000	0	0	0	2,300,000
equity in net income of nonconsolidated companies, net of dividends															1,300,000	7,600,000	7,500,000	14,900,000	32,400,000	29,800,000	20,000,000	25,200,000	24,600,000	11,200,000	3,600,000				3,300,000												1,400,000		4,100,000
net proceeds from settlement of interest rate swaps																		0	0
proceeds from long-term debt
collection of transferred receivables																	86,600,000
amortization of acquired inventory																						0	-200,000	-4,100,000	-1,200,000	-1,800,000	-1,500,000	-15,800,000	-30,100,000													9,300,000	4,200,000
impairment of goodwill
colonsay and plant city closure costs
gain on disposal of fixed assets
changes in assets and liabilities, net of acquisitions:
proceeds from sale of assets
acquisition, net of cash acquired																										0	0	9,300,000	-994,600,000
impairment, restructuring and other incomes
purchase of assets																							0
investments in nonconsolidated companies																														0				0	-144,000,000			-102,100,000	0	-122,000,000	-3,000,000	-2,600,000	-2,400,000	-143,800,000	-5,800,000	-134,500,000																									-300,000
investments in consolidated affiliate																										2,100,000	0	-4,900,000	1,300,000	-1,800,000	-8,800,000	-13,900,000	-25,000,000
payment of financing costs
plant city closure costs																							-15,600,000
loss on sale of fixed assets																							4,900,000
changes in assets and liabilities, excluding effects of acquisition:
proceeds from sale of fixed assets																													1,200,000
loss on write-down of long-lived asset																																		0	-3,500,000
cash, cash equivalents and restricted cash—beginning of period
cash, cash equivalents and restricted cash—end of period
equity in net income (earnings) of nonconsolidated companies, net of dividends																											9,400,000				-9,700,000			2,500,000											3,300,000													8,500,000
(gain) loss on sale of fixed assets																													400,000
(gain) loss on disposal of fixed assets
proceeds from adjustment to acquisition of business																																						0	0	0	47,900,000
return of investment from nonconsolidated companies																																						0
net cash (used in) investing activities
net change in cash and cash equivalents																																		19,600,000	-405,800,000	1,600,000	-218,600,000	-8,600,000	-925,000,000	-307,500,000	142,800,000	-596,000,000	603,600,000	-123,700,000	-2,802,400,000	-576,900,000	374,400,000	-98,000,000	-174,100,000	-216,200,000	609,100,000	-425,700,000	-410,400,000	131,600,000	-307,300,000	1,296,700,000	-160,300,000	-356,300,000	49,400,000	-104,500,000	-282,600,000	621,900,000	229,000,000	492,000,000	3,000,000	218,600,000	191,300,000	53,600,000	41,500,000	-43,700,000	-11,400,000
cash and cash equivalents—beginning of period																																															0	0	0	3,811,000,000	0	0	0	3,906,400,000	0	0	2,523,000,000	0	0	2,703,200,000	0	0	1,960,700,000	0	0	420,600,000	0	0	173,300,000	245,000,000
cash and cash equivalents—end of period																																															374,400,000	-98,000,000	-174,100,000	3,594,800,000	609,100,000	-425,700,000	-410,400,000	4,038,000,000	-307,300,000	1,296,700,000	2,362,700,000	-356,300,000	49,400,000	2,598,700,000	-282,600,000	621,900,000	2,189,700,000	492,000,000	3,000,000	639,200,000	191,300,000	53,600,000	214,800,000	201,300,000	-11,400,000
proceeds from settlement of swaps																																				0	4,200,000
proceeds from stock option exercises																																			1,200,000	1,800,000	800,000		1,100,000	1,300,000	2,900,000		1,000,000	1,100,000	200,000	500,000
change in value of share repurchase agreement																																										0	-5,300,000	5,500,000	60,000,000
carlsbad restructuring expense																																										58,400,000
restricted cash																																		229,000,000				0									0	4,500,000	-4,300,000	4,900,000	3,000,000	1,200,000	2,600,000	-1,500,000	-11,700,000			0								-200,000
proceeds from sale of businesses																																																																400,000	-300,000	7,800,000
acquisition of businesses
net cash (used in) financing activities
investments in affiliate																																			-40,000,000	-51,500,000	-38,500,000
equity in net earnings of nonconsolidated companies, net of dividends																																				19,800,000	7,600,000		2,700,000							7,000,000		600,000	-4,700,000	9,300,000							-3,800,000			-2,500,000	-6,000,000	-29,100,000	-27,700,000							-10,200,000
deferred income taxes																																						102,600,000	-55,700,000	32,000,000	-31,500,000	-56,400,000	-5,400,000	-33,100,000	-58,900,000		224,100,000	600,000	-55,100,000	30,400,000	164,000,000	-47,600,000	76,800,000	52,600,000	52,200,000	36,500,000	-30,400,000	1,100,000	23,300,000	11,600,000	-46,700,000	149,300,000	15,300,000							57,600,000
(gain) loss on assets sold and to be sold																																										9,700,000
accounts payable																																						-75,800,000	249,800,000	125,800,000	2,000,000	4,900,000	6,500,000	179,000,000	86,800,000	-104,100,000	-3,200,000	-114,300,000	45,000,000	-28,000,000	93,700,000	-3,400,000	-114,500,000	-34,200,000	95,300,000	26,500,000	-27,500,000	-26,300,000	34,800,000	77,000,000	-444,600,000	-476,200,000	273,900,000							-800,000	-20,000,000
accrued liabilities																																																											-121,500,000	-299,800,000	-69,700,000	-357,700,000	138,200,000
realized loss on interest rate swap
repurchase of stock
(gain) on assets sold and to be sold
accrued liabilities and income taxes																																							-28,200,000	-62,600,000	82,000,000		-104,000,000	94,600,000	77,200,000	-221,000,000		-11,700,000	-150,300,000	-79,100,000		29,900,000	-115,100,000	-130,000,000	49,700,000	-68,000,000	116,200,000
supplemental disclosure of cash flow information:
cash paid during the period for:
interest																																								58,900,000	4,400,000		1,300,000							3,900,000				13,900,000	34,400,000	-11,200,000	32,900,000	33,800,000	-6,800,000	39,600,000	43,600,000	500,000	47,400,000	55,600,000	16,000,000	63,400,000	85,300,000	10,100,000	96,100,000
income taxes																																								91,600,000	46,400,000		-21,600,000	36,000,000	24,300,000			80,000,000	103,200,000	82,300,000		119,900,000	185,400,000	150,100,000	128,000,000	229,300,000	77,200,000	118,100,000	103,500,000	271,000,000	155,400,000	567,800,000	192,700,000	104,800,000	48,500,000	48,500,000	19,900,000	19,400,000	18,000,000
payment of tender premium on debt																																																										-200,000	0	-5,500,000			-200,000
contributions by cargill
cash and cash equivalents—december 31																																												0	5,293,100,000
cash and cash equivalents—june 30																																														3,915,500,000
cash and cash equivalents—march 31																																													2,490,700,000
loss on write-down of assets																																														122,800,000
unrealized (gain) on derivatives																																														-40,700,000
dividends																																														-106,800,000		-106,700,000	-106,700,000	-106,600,000
cash and cash equivalents—september 30																																														3,338,600,000
excess tax benefits related to share-based compensation
proceeds from sale of equity investment																																																							0
distributions received from equity investments
proceeds from stock options exercised																																																			500,000	200,000	1,100,000	1,200,000	8,000,000	9,200,000	1,500,000	5,800,000	2,800,000	2,200,000	200,000	3,000,000	1,100,000	11,200,000	19,200,000	18,400,000	14,500,000	20,400,000	1,500,000	23,500,000
repurchase of class a common stock																																																			0	0
proceeds from stock option exercise																																																2,100,000	500,000	1,700,000
net earnings including non-controlling interests																																																							542,600,000	1,026,800,000	298,900,000	223,500,000	109,000,000	102,500,000
adjustments to reconcile net earnings including non-controlling interests to net cash from operating activities:
equity in loss of nonconsolidated companies, net of dividends
equity in loss (earnings) of nonconsolidated companies, net of dividends																																																					200,000	700,000
excess tax benefit related to stock option exercises																																																							-5,900,000	-5,500,000	-700,000
equity in (net earnings) loss of nonconsolidated companies, net of dividends
stock-based compensation expense																																																								3,000,000	13,100,000	3,100,000	3,200,000	14,200,000
purchase of equity investment																																																								0	-385,300,000
dividends paid to non-controlling interests
dividend paid to minority shareholder																																																									-100,000	0	-800,000	-100,000	-300,000	-400,000	-1,400,000	-1,600,000	-3,400,000	-100,000
balance as of may 31, 2009																																																									444,500,000	0	0	444,500,000
net earnings including non-controlling interest
foreign currency translation adjustment, net of tax of 41.3
net actuarial loss and prior service cost, net of tax of 34.0 million
comprehensive income
stock option exercises																																																									900,000	0	0	600,000
amortization of stock based compensation
dividends for non-controlling interests
tax benefits related to share based compensation
balance as of may 31, 2010																																																									445,400,000
foreign currency translation net of tax of 0.3 million
net actuarial gain and prior service cost, net of tax benefit of 13.2 million
tax shortfall related to share based compensation
balance as of august 31, 2010																																																									445,600,000
lower of cost or market write-down																																																													28,300,000
proceeds from saskferco note receivable																																																													0
excess tax benefits related to stock option exercises																																																										-3,300,000	500,000	-400,000	0	-2,000,000	-2,800,000
balance as of may 31, 2008																																																										0	0	443,900,000
adoption of new defined benefit pension and postretirement measurement guidance, net of tax of 0.2
beginning balance, as adjusted																																																										0	0	443,900,000
net earnings																																																													58,800,000	959,800,000	1,184,700,000							76,100,000	38,800,000
foreign currency translation adjustment, net of tax of 13.3
net actuarial loss, net of tax of 31.2
comprehensive income for 2009
distributions to cargill, inc.
tax benefits related to stock option exercises
foreign currency translation adjustment, net of tax of 3.2
net actuarial loss
balance as of february 28, 2010
other current assets																																																											1,700,000	8,900,000			-55,100,000							-7,300,000	29,600,000
foreign currency translation adjustment, net of tax of 3.5
balance as of november 30, 2009
adoption of fas 158 measurement date, net of tax of 0.2
dividends paid
foreign currency translation adjustment, net of tax of 4.2
net actuarial loss, net of tax of 0
comprehensive income for 2010
balance as of august 31, 2009																																																												444,900,000
adjustments to reconcile net earnings to net cash from operating activities:
minority interest																																																													-700,000	1,600,000	3,800,000							2,200,000	-500,000
amortization of out-of-market contracts																																																													-3,100,000									-4,500,000
amortization of stock-based compensation expense																																																													3,600,000	3,800,000	10,100,000
gain on sale of equity method investment																																																													0
proceeds from sale of equity method investment																																																													0
payments of restricted cash																																																													3,700,000	-31,100,000	-1,200,000
contributions from cargill, incorporated																																																																2,200,000
basic weighted-average common shares outstanding																																																													100,000	200,000	444,100,000
common stock issuable upon vesting of restricted stock awards																																																													-100,000	-100,000	600,000
common stock equivalents																																																													-300,000	-500,000	1,800,000
diluted weighted-average common shares outstanding																																																													-300,000	-400,000	446,500,000
earnings per share—basic																																																													-2,030,000	-510,000	2,670,000
earnings per share—diluted																																																													-2,020,000	-500,000	2,650,000
restructuring and other charges
proceeds from sale of investment
payments for deferred financing costs
payment for swap termination
proceeds from note receivable from saskferco products inc.
payments on debt due to cargill, inc. and affiliates
effect of exchange rate changes on cash and cash equivalents																																																																			14,400,000
cash acquired in acquisition of imc global inc.
proceeds from (investment in) note of saskferco products, inc.
investment in nonconsolidated companies
payments of short-term and long-term debt																																																																						-71,700,000
proceeds from issuance of short-term and long-term debt																																																																						14,000,000
contributions by cargill, inc.
changes in short-term and long-term debt due to cargill, inc and affiliates
increase in debt refinancing and issuance costs
cumulative effect of a change in accounting principle																																																																							0
settlement of asset retirement obligations																																																																						-6,800,000
amortization of fair market value adjustment of debt																																																																						-12,000,000
amortization of debt financing fees and stock-based compensation expense																																																																						2,700,000
pension and postretirement obligations funding																																																																						-8,200,000
unrealized gains on derivatives																																																																						-61,300,000
other charges																																																																						200,000	7,400,000
other credits																																																																						-5,800,000	-26,300,000
accrued expenses																																																																						-24,500,000	-77,800,000
other current liabilities																																																																						7,600,000	15,100,000
due to/from cargill, incorporated and affiliates																																																																						26,300,000	18,800,000
proceeds from (investment in) note of saskferco products inc.																																																																						11,800,000
proceeds from the sale of assets																																																																						500,000	100,000
contributions by cargill, incorporated
changes in short-term and long-term debt due to cargill, incorporated and affiliates																																																																						-100,000	-29,000,000
deferred income taxes, exclusive of acquisition
increase in equity earnings in nonconsolidated companies, net of dividends
changes in assets and liabilities, exclusive of acquisition:
acquisition of imc global inc., net of cash acquired																																																																							0
investment in note of saskferco products inc.																																																																							-300,000
investments in businesses acquired and minority interests
changes in short-term debt																																																																							28,300,000
stock options exercised and restricted stock awards																																																																							16,000,000
debt refinancing and issuance costs
cash and cash equivalents—beginning of year																																																																							0
non cash investing activities:
issuance of mosaic common stock, preferred stock and stock options in exchange for imc common stock, preferred stock and stock options																																																																							0
non cash financing activities:
contributions from cargill, incorporated to convert short and long-term debt to common stock and capital in excess of par value																																																																							10,300,000
increase in equity in nonconsolidated companies, net of dividends
increase in restricted cash
cash dividends paid to cargill, incorporated

We provide you with 20 years of cash flow statements for The Mosaic stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of The Mosaic stock. Explore the full financial landscape of The Mosaic stock with our expertly curated income statements.

The information provided in this report about The Mosaic stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.